Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Advertising & Marketing

Sales

Legal & Regulatory

Acquisition & Integration

Goodwill impairment

Restructuring costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Teladoc

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. Its portfolio of services and solutions covers medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. The company was founded on June 13, 2002, by George Byron Brooks and Gary Wald and is headquartered in Purchase, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Teladoc reports solid Q4 growth, eyes revenue optimization strategies

Teladoc's Q4 performance showed revenue growth and margin focus, with BetterHelp contributing significantly to profitability.
The company's strategic focus on virtual care expansion and revenue optimization positions Teladoc for continued success in the healthcare market.
While facing internal restructuring challenges, Teladoc's emphasis on growth drivers and operational efficiency presents opportunities for future growth and market leadership.

Teladoc Health excels in Q1, eyes growth and efficiency

Teladoc Health's Q1 performance was strong, with revenue exceeding expectations.
The company is focused on efficiency, innovation, and driving value in virtual care.
BetterHelp segment showed growth and stability, with improving margins expected.
Opportunities exist to capitalize on ad pricing stability and consumer behavior trends.

Teladoc surpasses revenue expectations, focuses on innovation and growth

Teladoc's Q2 performance exceeded expectations, with strong revenue growth and improved margins in both segments. The company's strategic focus on whole-person care, weight management, and AI enhancements positions it well for future growth. Challenges include managing drug costs and private company valuations, while opportunities lie in virtual care demand and strategic M&A.
Teladoc's financial strength, commitment to innovation, and focus on efficiency improvements are key strengths driving its performance. The company's ability to navigate challenges and capitalize on opportunities in the evolving healthcare landscape underscores its resilience and growth potential.

Teladoc Health surpasses Q3 expectations, eyes margin expansion in '24

Teladoc Health's Q3 performance exceeded expectations, driven by revenue growth and margin improvements.
The company is focused on enhancing cost efficiencies, profitability, and driving margin expansion.
Stable pricing environment and strong client demand present opportunities for future growth.
Operational review and strategic initiatives position Teladoc for continued success in the healthcare sector.

Teladoc reports robust 2023 earnings, eyes growth amid marketing challenges

Teladoc delivered strong financial performance in 2023 with notable growth in adjusted EBITDA and revenue. The company faces challenges in BetterHelp marketing yields and delayed consumer engagement efforts.
However, Teladoc's strategic strengths lie in its long-term outlook for revenue growth, margin expansion, and cost-saving initiatives. Opportunities exist in optimizing sales force structure and capital deployment for future growth.
Overall, Teladoc's focus on profitability, growth optimization, and strategic capital allocation positions it well for sustained success in the telehealth industry.

Teladoc Health reports solid Q1 performance amidst revenue challenges

Teladoc Health's Q1 2024 performance showcased revenue growth in Integrated Care but challenges in BetterHelp segment revenue and margin management.
The company's financial strength, product portfolio, and cost initiatives position it well for growth opportunities and strategic market positioning.
Addressing challenges in ad spend management and focusing on international market efficiency are key to unlocking growth potential and improving financial performance.
Overall, Teladoc's performance, strengths, challenges, and opportunities reflect a dynamic landscape with strategic focus on sustainable growth and operational efficiency.

Teladoc Health reports Q2 revenue dip, EBITDA growth; addresses challenges

Teladoc Health's Q2 2024 performance showed mixed results with revenue decline but EBITDA growth. The company is leveraging strengths in patient safety and technology while addressing challenges in customer acquisition costs. Opportunities lie in operational efficiency, insurance coverage access, and international expansion.

Teladoc Health reports Q3 revenue decline but strategic growth

Teladoc Health's Q3 2024 performance reflects mixed results with revenue decline but strategic growth in the Integrated Care segment.
The company's focus on customer-centric strategies, technology, and clinical excellence positions it well for future success and market leadership.
Challenges in revenue decline and expense management require Teladoc Health to balance short-term financial performance with long-term growth objectives.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002, by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in Purchase, NY.

Teladoc Health's (TDOC) first industry-standard model to help employers improve their package of telehealth services.

Teladoc Health's (TDOC) Virtual Care Model to Aid Companies

An analyst at a prominent investment bank cuts her price target on the company's shares.

Why Teladoc Health Was Looking Sickly on Monday

This first-of-its-kind framework provides a clear roadmap to evolve virtual health care benefits This first-of-its-kind framework provides a clear roadmap to evolve virtual health care benefits

Teladoc Health Announces Virtual Care Transformation Model for Employers

BARK

Fastly

Novavax

Ping Identity Holding Corp

Pinterest

Pubmatic

PayPal

Stock market corrections have always been the ideal time to put money to work.

10 Stocks I've Bought During the Market Sell-Off

The digital healthcare provider's stock is falling hard this year, but that doesn't mean the business isn't thriving.

Teladoc's Long-Term Prospects Have Never Looked Better

Teladoc stock has been on a downward spiral. But after taking a deeper look at its 2021 financial results, there is a lot to encourage investors.

Teladoc Is Down but Not Out -- Here's Why

AbbVie

Medical Properties Trust

These stocks have doubled returns over the past five years and look poised to do it again.

3 Medical Stocks That Could Double Your Returns in the Long Run

MercadoLibre

Their share prices are beaten down, but their underlying businesses are strong.

3 Growth Stocks You Won't Regret Buying in This Market Correction

Will Teladoc Ever Top $200 Again?

UiPath

Roku

Spotify

Unity Software

Vertex Pharmaceuticals

Many Cathie Wood stocks have suffered losses over the past year, but these companies will likely see strong gains in the coming quarters. The post 7 Cathie Wood Stocks That Are Worth Buying in March appeared first on InvestorPlace.

7 Cathie Wood Stocks That Are Worth Buying in March

Teladoc Health, Inc. (TDOC) Presents at Cowen 42nd Annual Healthcare Conference (Transcript)

Teladoc recently announced its plan to launch medical virtual care services on Amazon's Alexa.

Alexa, Say Hello To Teladoc

Teladoc's Cash Flow to CapEx is looking much better.

Teladoc Stock: Why We're Buying Into The Drawdown

Innovative Industrial Properties

All three are leaders in their respective markets and have huge growth opportunities.

Got $2,000? Buy These 3 Unstoppable Stocks

A lot of things are going right, but there's still one troublesome factor.

3 Reasons to Buy Teladoc Stock and 1 Reason to Sell

Lucid Group

Zillow

Most of the market's most-shorted stocks are rarely worth a purchase, but when they're leading, large-cap tech names, there does come a time. The post 3 Large-Cap Technology's Most-Shorted Stocks to Buy appeared first on InvestorPlace.

3 Large-Cap Technology's Most-Shorted Stocks to Buy

ARK Innovation ETF

DraftKings

Twilio

Amid first-quarter struggles for growth stocks, some members of this category are trading at discounts relative to their histories of often lofty valuations. Perhaps surprisingly, some names with the disruptive growth label are in the discounted growth stock conversation.

There's Some Value to Be Had With Growth Stocks

For this year, Teladoc Health (TDOC) projects total visits in the band of 18.5-20 million, indicating a rise from the 2021 level of 15.4 million.

Teladoc Health (TDOC) Tumbling: Is it Healthy for Your Portfolio?

Does Teladoc's Collaboration With Amazon Make Its Stock a Buy?

This isn't how upgrades are supposed to work.

Why Teladoc Stock Tanked Today

Teladoc Health was a pandemic darling. Does the investing thesis still hold up?

Is This Crushed Telehealth Stock Worth a Second Look?

Should Teladoc Shareholders Be Worried About Amazon?

Teladoc's battered and bruised stock could have brighter days ahead.

Teladoc: When Valuation Sets a Low Bar

Don't give up on this healthcare stock just yet.

3 Reasons to Buy Teladoc Stock -- and Never Sell

Deutsche Bank analyst views the partnership with Amazon Inc (NASDAQ: AMZN) as a "very modest win" for Teladoc Inc (NYSE: TDOC).  The analyst, George Hill, never saw Amazon as a serious threat in telemedicine, and he considers the move to be "another.

News for Teladoc Stock (TDOC)